Claus Torp Jensen - Dec 1, 2023 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
CHIEF INNOVATION OFFICER
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
Dec 1, 2023
Transactions value $
$0
Form type
4
Date filed
12/5/2023, 04:08 PM
Previous filing
Sep 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +2.81K +17.71% 18.7K Dec 1, 2023 Direct F1
transaction TDOC Common Stock Options Exercise +2.04K +10.95% 20.7K Dec 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -2.81K -16.66% $0.00 14K Dec 1, 2023 Common Stock 2.81K Direct F1, F2
transaction TDOC Restricted Stock Units Options Exercise $0 -2.04K -14.28% $0.00 12.3K Dec 1, 2023 Common Stock 2.04K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Claus Torp Jensen is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 On March 1, 2022, the reporting person was granted 33,688 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F3 On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.